Post a Free Blog

Submit A Press Release

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Action
Animation
ATP Tour (ATP)
Auto Racing
Baseball
Basketball
Boxing
Breaking News
Business
Business
Business Newsletter
Call of Duty (CALLOFDUTY)
Canadian Football League (CFL)
Car
Celebrity
Champions Tour (CHAMP)
Comedy
CONCACAF
Counter Strike Global Offensive (CSGO)
Crime
Dark Comedy
Defense of the Ancients (DOTA)
Documentary and Foreign
Drama
eSports
European Tour (EPGA)
Fashion
FIFA
FIFA Women’s World Cup (WWC)
FIFA World Cup (FIFA)
Fighting
Football
Formula 1 (F1)
Fortnite
Golf
Health
Hockey
Horror
IndyCar Series (INDY)
International Friendly (FRIENDLY)
Kids & Family
League of Legends (LOL)
LPGA
Madden
Major League Baseball (MLB)
Mixed Martial Arts (MMA)
MLS
Movie and Music
Movie Trailers
Music
Mystery
NASCAR Cup Series (NAS)
National Basketball Association (NBA)
National Football League (NFL)
National Hockey League (NHL)
National Women's Soccer (NWSL)
NBA Development League (NBAGL)
NBA2K
NCAA Baseball (NCAABBL)
NCAA Basketball (NCAAB)
NCAA Football (NCAAF)
NCAA Hockey (NCAAH)
Olympic Mens (OLYHKYM)
Other
Other Sports
Overwatch
PGA
Politics
Premier League (PREM)
Romance
Sci-Fi
Science
Soccer
Sports
Sports
Technology
Tennis
Thriller
Truck Series (TRUCK)
True Crime
Ultimate Fighting Championship (UFC)
US
Valorant
Western
Women’s National Basketball Association (WNBA)
Women’s NCAA Basketball (WNCAAB)
World
World Cup Qualifier (WORLDCUP)
WTA Tour (WTA)
Xfinity (XFT)
XFL
0
-- Advertisement --spot_img
HomeBusinessJefferies Financial Group Inc. (NYSE:JEF) Sees Varied Analyst Confidence and Strong Fiscal...

Jefferies Financial Group Inc. (NYSE:JEF) Sees Varied Analyst Confidence and Strong Fiscal Performance

Add to Favorite
Added to Favorite


Jefferies Financial Group Inc. (NYSE:JEF) has experienced fluctuations in its consensus price target, reflecting varying levels of analyst confidence.
The company is expected to see a boost in its first-quarter fiscal 2025 results, despite challenges from high costs.
Jefferies reported impressive quarterly earnings of $1.05 per share, surpassing the Zacks Consensus Estimate.

Jefferies Financial Group Inc. (NYSE:JEF) is a diversified financial services company that operates in investment banking, capital markets, and asset management. The company has experienced fluctuations in its consensus price target over the past year, reflecting varying levels of analyst confidence. Last month, the average price target was $78, a slight decrease from the previous quarter’s $82.5, but a significant increase from last year’s $67.4.
Jefferies is expected to see a boost in its first-quarter fiscal 2025 results due to modest investment banking and trading revenues. However, high costs could pose challenges to its overall performance. Despite these challenges, Jefferies is currently rated as a “Buy” at approximately $55, thanks to its improving operating efficiency and expanding market position.
The company reported strong fiscal Q4 earnings, driven by a robust rebound in its investment banking business and increased revenues from capital markets. Despite these positive results, Jefferies faces challenges due to rising expenses. Analyst Chris Kotowski from Oppenheimer has set a price target of $47 for Jefferies, indicating some caution in the stock’s future performance.
Jefferies has experienced a 4.5% decline in its stock price since its last earnings report, which was released 30 days ago. Investors are keen to understand the future trajectory of Jefferies’ stock following this recent performance. The company’s diverse revenue mix, balancing advisory fees with capital markets revenue, positions it well to capitalize on the broader market recovery.
Jefferies reported impressive quarterly earnings of $1.05 per share, surpassing the Zacks Consensus Estimate of $0.98 per share. This marks a significant improvement from the $0.30 per share reported in the same quarter last year. 

Subscribe to get Latest News Updates

Latest News

You may like more
more

VolitionRx Limited’s Upcoming Earnings Report: A Deep Dive into Financial Health and Future Prospects

VolitionRx Limited (NYSEAMERICAN:VNRX) is set to release its quarterly...

Recent Market Movements: Analysis of Top Losers

Milestone Pharmaceuticals Inc. (NASDAQ:MIST) saw a dramatic decrease of...

Ovintiv Inc. (NYSE: OVV) Set to Announce First Quarter 2025 Results

Ovintiv Inc. (NYSE:OVV) receives an upgrade from BMO Capital...